Kala Pharmaceuticals to present preclinical data on mucosal-penetrating particle technology

NewsGuard 100/100 Score
Editorial Checklist Reviewed
Jul 20 2013Kala Pharmaceuticals

Kala Pharmaceuticals, Inc., a leading developer of innovative products that rapidly and effectively penetrate the mucosal barrier to treat ocular diseases, announced today that Kala researchers will present preclinical data at the upcoming Controlled Release Society (CRS) 2013 Annual Meeting taking place July 21-24, 2013, in Honolulu, HI. The poster presentation will highlight the capability of Kala's proprietary Mucosal-Penetrating Particle (MPP) technology to enhance topical drug delivery to the front and back of the eye.

“Mucosal-Penetrating Particles Enable Topical Delivery to Posterior Segment of the Eye”

Poster Presentation:

(Abstract #100749, Poster #696): Monday, July 22, 2013, 9:30-10:30am HST, "Mucosal-Penetrating Particles Enable Topical Delivery to Posterior Segment of the Eye" Elizabeth Enlow, Kala Pharmaceuticals, Poster Session #1, Hawaii Convention Center.

Source:

Kala Pharmaceuticals

Posted in: Device / Technology News | Pharmaceutical News

Tags: , , , , , ,

Comments (0)

Suggested Reading

Breaking through new research barriers with iPSC technology
Genes and age reveal new insights into cognitive variability, study finds
From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech
Do flavonoids enhance cognitive function?
Wearable biosensors with skin interfaces for newborn and neonatal health monitoring
Bats in China found to carry novel herpesviruses, hinting at cross-species transmission dangers
Chatbots for mental health pose new challenges for US regulatory framework
Research quantifies impact of childhood obesity on long-term health and life expectancy

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Does internet use boost psychological well-being?